Fenju Liu

1.2k total citations
42 papers, 938 citations indexed

About

Fenju Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fenju Liu has authored 42 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Fenju Liu's work include MicroRNA in disease regulation (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer-related Molecular Pathways (4 papers). Fenju Liu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer-related Molecular Pathways (4 papers). Fenju Liu collaborates with scholars based in China, Taiwan and United States. Fenju Liu's co-authors include Wei Yang, Jing Wei, Zhongmin Wang, Ting Sun, Jiahua Yu, Gang Huang, Kemin Chen, Jianping Cao, Jian Lu and Wei Zhu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Fenju Liu

42 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fenju Liu China	19	485	341	260	169	140	42	938
Ye Tian China	18	382 0.8×	246 0.7×	191 0.7×	229 1.4×	180 1.3×	79	867
Yun-Fei Xia China	21	461 1.0×	277 0.8×	508 2.0×	207 1.2×	213 1.5×	40	1.2k
Qingfang Li China	17	437 0.9×	235 0.7×	336 1.3×	222 1.3×	102 0.7×	37	1.0k
Guido Giordano Italy	16	267 0.6×	225 0.7×	493 1.9×	179 1.1×	104 0.7×	76	916
Annett Linge Germany	15	445 0.9×	238 0.7×	321 1.2×	160 0.9×	46 0.3×	42	893
Yozo Suzuki Japan	15	652 1.3×	255 0.7×	407 1.6×	275 1.6×	200 1.4×	64	1.1k
Sherry J. Lim United States	12	564 1.2×	343 1.0×	674 2.6×	140 0.8×	244 1.7×	17	1.2k
Ricardo Costa Brazil	16	504 1.0×	299 0.9×	403 1.6×	211 1.2×	95 0.7×	17	1.1k
Gang Peng China	16	472 1.0×	328 1.0×	275 1.1×	372 2.2×	279 2.0×	44	1.2k

Countries citing papers authored by Fenju Liu

Since Specialization

Citations

This map shows the geographic impact of Fenju Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenju Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenju Liu more than expected).

Fields of papers citing papers by Fenju Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenju Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenju Liu. The network helps show where Fenju Liu may publish in the future.

Co-authorship network of co-authors of Fenju Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenju Liu. A scholar is included among the top collaborators of Fenju Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenju Liu. Fenju Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Fei, Zhongmin Wang, Jianghong Zhang, et al.. (2020). TIGAR/AP-1 axis accelerates the division of Lgr5− reserve intestinal stem cells to reestablish intestinal architecture after lethal radiation. Cell Death and Disease. 11(7). 501–501. 10 indexed citations

Du, Jie, Ting Xie, Xia Ning, et al.. (2018). Quantitative assessment of HR and NHEJ activities via CRISPR/Cas9-induced oligodeoxynucleotide-mediated DSB repair. DNA repair. 70. 67–71. 30 indexed citations

Huang, Jianfeng, Qingfeng Pang, Haowen Zhang, et al.. (2018). Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells. Drug Design Development and Therapy. Volume 12. 2223–2231. 11 indexed citations

Du, Jie, Jun Shang, Fei Chen, et al.. (2017). A CRISPR/Cas9–Based Screening for Non-Homologous End Joining Inhibitors Reveals Ouabain and Penfluridol as Radiosensitizers. Molecular Cancer Therapeutics. 17(2). 419–431. 16 indexed citations

Chen, Fei, Jiaojiao Wang, Jun Shang, et al.. (2017). TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport. Scientific Reports. 7(1). 42928–42928. 21 indexed citations

Zhou, Yuan, Hua Song, Jiahua Yu, et al.. (2015). A strategy for effective radioprotection by chitosan-based long-circulating nanocarriers. Journal of Materials Chemistry B. 3(15). 2931–2934. 31 indexed citations

Li, Ming, Yanchao Ma, Shuyu Zhang, et al.. (2015). Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells. Gene. 560(2). 237–244. 26 indexed citations

Yang, Chen, Ran Zhu, Jianmei Wan, et al.. (2014). Biological Effects of Irradiating Hepatocellular Carcinoma Cells by Internal Exposure with ¹²⁵ I-Labeled 5-Iodo-2′-Deoxyuridine-Chitosan Drug Loading Nanoparticles. Cancer Biotherapy and Radiopharmaceuticals. 29(9). 395–402. 8 indexed citations

Yang, Wei, et al.. (2014). Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance. Experimental Cell Research. 326(1). 22–35. 67 indexed citations

10.

Liu, Fenju. (2013). Effects of DCX and SPARC co-expression on the apoptosis of human glioma cells U-87MG induced by X-rays irradiation. 1 indexed citations

11.

Liu, Fenju. (2013). Research status and development tendency of welding technology of AZ31B magnesium alloy. Ordnance Material Science and Engineering. 1 indexed citations

12.

Yu, Jingping, et al.. (2011). Enhancement of Radiosensitivity and the Potential Mechanism on Human Esophageal Carcinoma Cells by Tetrandrine. Cancer Biotherapy and Radiopharmaceuticals. 26(4). 437–442. 18 indexed citations

13.

Yu, Jingping, et al.. (2011). The Enhancement of Radiosensitivity in Human Esophageal Carcinoma Cells by Thalidomide and Its Potential Mechanism. Cancer Biotherapy and Radiopharmaceuticals. 26(2). 219–227. 13 indexed citations

14.

Liu, Haiyan, et al.. (2011). Knockdown of Secreted Protein Acidic and Rich in Cysteine ( SPARC ) Expression Diminishes Radiosensitivity of Glioma Cells. Cancer Biotherapy and Radiopharmaceuticals. 26(6). 705–715. 6 indexed citations

15.

Wang, Zhong-Min, Jian Lu, Tao Liu, et al.. (2011). CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer. Lung Cancer. 74(2). 253–257. 44 indexed citations

16.

Wang, Zhongmin, Jian Lu, Lin Liu, et al.. (2011). Clinical application of CT-guided 125I seed interstitial implantation for local recurrent rectal carcinoma. Radiation Oncology. 6(1). 138–138. 21 indexed citations

17.

Wang, Bo, et al.. (2010). Biologic characteristics of the side population of human small cell lung cancer cell line H446. Chinese Journal of Cancer. 29(3). 254–260. 31 indexed citations

18.

Liu, Fenju. (2009). Progress of research on activation function of NK cell exposed to low dose radiation in adoptive cellular immunotherapy. 1 indexed citations

19.

Liu, Fenju, et al.. (2009). Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation. Radiation and Environmental Biophysics. 48(4). 371–378. 9 indexed citations

20.

Xu, Dongsheng, et al.. (2008). Effort of fast-neutron and X-ray on expression of p53 and CyclinB1 of small intestinal tissue in mice. Nuclear Techniques. 31(8). 625–628. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact